phenytoin and gyki 52466

phenytoin has been researched along with gyki 52466 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bahare, RS; Khan, SA; Malik, S1
Blaustein, MP; Juhng, KN; Kim, BY; Kokate, TG; Rogawski, MA; Rogowski, RS; Yamaguchi, S1

Other Studies

2 other study(ies) available for phenytoin and gyki 52466

ArticleYear
Design, synthesis and anticonvulsant evaluation of N-(benzo[d]thiazol-2-ylcarbamoyl)-2-methyl-4-oxoquinazoline-3(4H)-carbothioamide derivatives: a hybrid pharmacophore approach.
    European journal of medicinal chemistry, 2013, Volume: 67

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Disease Models, Animal; Drug Design; Electroshock; Injections, Intraperitoneal; Mice; Molecular Structure; Quinazolines; Rats; Rats, Wistar; Seizures; Thiazoles; Thioamides

2013
Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-K(alpha) and pandinustoxin-K(alpha).
    Epilepsy research, 1999, Volume: 34, Issue:2-3

    Topics: 4-Aminopyridine; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Mice; Neuroprotective Agents; Phenytoin; Potassium Channel Blockers; Scorpion Venoms; Seizures

1999